FGF23 and hypophosphatemia: Tumor-induced osteomalacia (TIO), also known as oncogenic osteomalacia, is a rare paraneoplastic syndrome caused by tumors secreting fibroblast growth factor-23 (FGF23), a hormone inducing renal phosphate wasting and subsequent hypophosphatemia.